Gene targeted ablation of high molecular weight fibroblast growth factor-2

Developmental Dynamics

Volumn 238, Issue 2, 2009, Pages 351-357

  Azhar, Mohamad ^a,d   Yin, Moying ^b   Zhou, Ming ^c   Li, Hongqi ^a   Mustafa, Marwan ^a   Nusayr, Eyad ^a   Keenan, Jack B ^a   Chen, Hwudaurw ^a   Pawlosky, Sharon ^b   Gard, Connie ^a   Grisham, Christina ^b   Sanford, L Philip ^a   Doetschman, Tom ^a,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

Angiogenesis; Bone formation; Cardiac capillary; Cardiac hypertrophy; Fibroblast growth factor; High molecular weight isoforms; Ischemia reperfusion injury; Knockout mice; Neurogenesis; Single nucleotide polymorphism; Tag and exchange; Tumor

Indexed keywords

FIBROBLAST GROWTH FACTOR 2;

ANIMAL EXPERIMENT; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HEART PROTECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CAPILLARIES; CORONARY VESSELS; FIBROBLAST GROWTH FACTOR 2; MICE; MICE, KNOCKOUT; MYOCARDIUM; PROTEIN ISOFORMS;

MUS;

EID: 59649100050     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21835     Document Type: Article

References (30)

1. Amann K, Faulhaber J, Campean V, Balajew V, Dono R, Mall G, Ehmke H. 2006. Impaired myocardial capillarogenesis and increased adaptive capillary growth in FGF2-deficient mice. Lab Invest 86: 45-53.
2. Askew GR, Doetschman T, Lingrel JB. 1993. Site-directed point mutations in embryonic stem cells: a gene- targeting tag-and-exchange strategy. Mol Cell Biol 13:4115-4124.
3. Bugler B, Amalric F, Prats H. 1991. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 11:573-577.
4. Chen K, Ohkubo Y, Shin D, Doetschman T, Sanford LP, Li H, Vaccarino FM. 2008. Decrease in excitatory neurons, astrocytes and proliferating progenitors in the cerebral cortex of mice lacking exon 3 from the Fgf2 gene. BMC Neurosci 9:94.
5. Coffin JD, Florkiewicz RZ, Neumann J, Mort-Hopkins T, Dorn GW Jr, Lightfoot P, German R, Howles PN, Kier A, O'Toole BA, Doetschman T. 1995. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 6:1861-1873.
6. Dailey L, Ambrosetti D, Mansukhani A, Basilico C. 2005. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16:233-247.
7. Davis MG, Zhou M, Ali S, Coffin JD, Doetschman T, Dorn GW. 1997. Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. J Mol Cell Cardiol 29:1061-1072.
8. Florkiewicz RZ, Anchin J, Baird A. 1998. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+,K+-ATPase. J Biol Chem 273:544-551.
9. Garmy-Susini B, Delmas E, Gourdy P, Zhou M, Bossard C, Bugler B, Bayard F, Krust A, Prats AC, Doetschman T, Prats H, Arnal JF. 2004. Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation. Circ Res 94:1301-1309.
10. House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, Schultz JJ. 2003. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation 108:3140-3148.
11. Hurley MM, Okada Y, Xiao L, Tanaka Y, Ito M, Okimoto N, Nakamura T, Rosen CJ, Doetschman T, Coffin JD. 2006. Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/-mice. Biochem Biophys Res Commun 341:989-994.
12. Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IM, Cattini PA, Kardami E. 2007. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol 42:222-233.
13. Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, Cattini PA. 2007. Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev 12:267-277.
14. Liao S, Porter D, Scott A, Newman G, Doetschman T, Schultz JJ. 2007. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling. J Mol Cell Cardiol 42:106-120.
15. Liao S, Bodmer J, Pietras D, Azhar M, Doetschman T, Schultz JE. 2008. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Dev Dyn [Epub ahead of print].
16. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM. 2000. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093.
17. Naganawa T, Xiao L, Coffin JD, Doetschman T, Sabbieti MG, Agas D, Hurley MM. 2008. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem 103:1975-1988.
18. Okada Y, Montero A, Zhang X, Sobue T, Lorenzo J, Doetschman T, Coffin JD, Hurley MM. 2003. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J Biol Chem 278:21258-21266.
19. Pusztaszeri MP, Seelentag W, Bosman FT. 2006. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385-395.
20. Raballo R, Rhee J, Lyn-Cook R, Leckman JF, Schwartz ML, Vaccarino FM. 2000. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J Neurosci 20:5012-5023.
21. Schultz JJ, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T. 1999. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 104:709-719.
22. Schultz JJ, Hoying JB, Sullivan C, Doetschman T. 2002. FGF and the cardiovascular system. In: Cuevas P, editor. Fibroblast growth factor in the cardiovascular system. Munich: Holzapfel Publishers. p 45-66.
23. Sheikh F, Sontag DP, Fandrich RR, Kardami E, Cattini PA. 2001. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am J Physiol 280:H1039-H1050.
24. Sorensen V, Nilsen T, Wiedlocha A. 2006. Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays 28:504-514.
25. Sridurongrit S, Larsson J, Schwartz R, Ruiz-Lozano P, Kaartinen V. 2008. Signaling via the Tgf-beta type I receptor Alk5 in heart development. Dev Biol 322: 208-218.
26. Steen AM, Sahlen S, Lambert B. 1991. Expression of the hypoxanthine phosphoribosyl transferase gene in resting and growth-stimulated human lymphocytes. Biochim Biophys Acta 1088:77-85.
27. Sullivan CJ, Doetschman T, Hoying JB. 2002. Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb. J Appl Physiol 93:2009-2017.
28. Vaccarino FM, Schwartz ML, Raballo R, Nilsen J, Rhee J, Zhou M, Doetschman T, Coffin JD, Wyland JJ, Hung YT. 1999. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 2:246-253.
29. Yu PJ, Ferrari G, Galloway AC, Mignatti P, Pintucci G. 2007. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J Cell Biochem 100:1100-1108.
30. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T. 1998. Fibroblast growth factor 2 control of vascular tone. Nat Med 4:201-207.